Immune Thrombocytopenia Induced by the Chimpanzee Adenovirus-Vectored Vaccine against SARS-CoV-2 Infection
We present a case of immune thrombocytopenia (ITP) induced by the chimpanzee adenovirus-vectored vaccine, without evidence of thrombosis, eight days after vaccine administration. The thrombocytopenia condition improved after administering steroid treatment. This adenovirus vaccine had been reported...
Main Authors: | Po-Wei Liao, Chieh-Lin Jerry Teng, Cheng-Wei Chou |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/9/12/1486 |
Similar Items
-
Innate Immune Responses to Chimpanzee Adenovirus Vector 155 Vaccination in Mice and Monkeys
by: Catherine Collignon, et al.
Published: (2020-11-01) -
Thrombotic events with or without thrombocytopenia in recipients of adenovirus-based COVID-19 vaccines
by: Luigi Cari, et al.
Published: (2022-09-01) -
Adenovirus 5 Vectors Expressing SARS-CoV-2 Proteins
by: Scott Bachus, et al.
Published: (2022-04-01) -
Stability of Chimpanzee Adenovirus Vectored Vaccines (ChAdOx1 and ChAdOx2) in Liquid and Lyophilised Formulations
by: Adam Berg, et al.
Published: (2021-10-01) -
Seroprevalence of Neutralizing Antibodies against Human Adenovirus Type-5 and Chimpanzee Adenovirus Type-68 in Cancer Patients
by: Hua Zhao, et al.
Published: (2018-03-01)